Skip Navigation

Funding

Funding opportunities within D&I aim to ensure that the lessons learned from research are relevant to, and, inform and improve – the quality of health, delivery of services and the utilization and sustainability of evidence-based tools and approaches. By closing the gap between research discovery and clinical and community practice, we hope to ensure that all populations benefit from the Nation’s investment in scientific discovery.

Funding Opportunities

  • The Division of Cancer Control and Population Sciences funds a large portfolio of grants and contracts. The portfolio currently includes over 900 grants valued at almost $400 million. This link directs you to grants that are specific to Implementation Science. A full listing of funding opportunities that are currently accepting applications is also available. Visit this page regularly, as new funding opportunities are added upon approval by NCI.
  • An archive of all of the Division of Cancer Control and Population Sciences funded grants and contracts are available, including the funding history for Implementation Science.

Grantmanship Resources

  • Helpful links for grant applications.
  • In January 2013, the Trans-NIH Funding Announcements for Dissemination and Implementation Research in Health (PAR-13-055 (R01); PAR-13-054 (R21); and PAR-13-056 (R03)) were re-issued. Two webinars were hosted as an opportunity for potential applicants interested in learning more about the re-issued announcements.

Research Portfolio

Currently funded and archived research portfolio for the Implementation Science funding opportunities:

  • Grant applications that identify, develop and refine effective and efficient methods, structures and strategies that test various models. The objective is to disseminate and implement research-tested health behavior change interventions and evidence-based prevention, early detection, diagnostic, treatment and quality of life improvement services in public health and clinical practice settings.
  • Administrative supplements for NCI-funded R01, P01, P50, U01 and U19 grants pertinent to cancer control.